Allergy and Immunology Foundation of Australasia (AIFA)

AIFA has been established by ASCIA to fund allergy and immunology research. We ensure that 100% of AIFA donations and sponsorships go directly to AIFA grants, which have funded 27 research projects since 2015. 

Donate to AIFA at  

National Allergy Centre of Excellence (NACE)

The NACE Postgraduate Research Scholarship program is being established to train and mentor Australia's next generation of allergy experts.  NACE PhD Scholarships have been offered in drug, food, insect and respiratory allergy research.

Centre for Food and Allergy Research (CFAR)

The CFAR website lists studies that are currently accepting participants in Australia: 


CIRCA is an Australasian  Garvan-led collaboration of medical and scientific professionals that investigates the genetic causes of rare immune diseases.. The mission of CIRCA is to understand the genetic causes of immunological diseases in individual patients. These findings are used to help improve outcomes for patients, their families and other individuals with similar immune diseases.


The ‘Australian survey of Multi-Disciplinary Low-Risk Penicillin Allergy delabelling’ is being conducted to explore current penicillin allergy delabelling practices performed by various disciplines in the Australian setting, and to ascertain attitudes, enablers and barriers towards multi-disciplinary penicillin allergy delabelling activity.
In Australia, low-risk penicillin allergy is common however timely access to penicillin allergy delabelling services is lacking. The results of this survey will help guide future research into improving access to antibiotic allergy delabelling pathways for all Australians. The survey should take less than 10 minutes to complete and can be accessed via this link:

Global Survey on Drug Allergy Management

ASCIA members are invited to participate in an international survey  that aims to improve the understanding of severe cutaneous adverse reactions (SCAR).. The diagnostic tools and management options for delayed drug reactions have been described in several consensus guidelines. However the clinical practice can vary between centres and countries, and there is a need to standardize practice, to improve patient care.. The survey (link below) should take no more than 10 minutes to complete:

The objectives of the Global appRoAch to Severe cutaneous adverse reactions Survey (GRASS) are to:

(1) evaluate the availability and utility of allergy testing for severe cutaneous adverse reaction (SCAR), 

(2) describe the management options for SCAR and 

(3) determine the knowledge of SCAR for the relevant physicians and health professionals.

Names and responses will remain anonymous.

CHOICE Allergen Immunotherapy Study 

CHOICE - “Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice: an international E-survey”.

The CHOICE study coordinators are looking for clinicians to join them in an international multi-center academic project (CHOICE) that looks at factors that drives the prescription of allergen immunotherapy in real-life clinical settings.

To be a part of this project, they require clinicians to complete a quick 10-minute web-based survey about current practice when prescribing allergen immunotherapy and also a short questionnaire for each patient that you are prospectively planning to commence on allergen immunotherapy.

For further information go to:


Biomedical and complementary medicine (CM) use in adults with eosinophilic oesophagitis (EoE)  - Survey

Are you living with eosinophilic esophagitis (EoE)? This international survey is being conducted by researchers from Southern Cross University (Australia) to understand what therapies adults with EoE use to manage their symptoms. The findings of this study will help identify potential treatment options for people living with EoE that could be examined further through clinical research. Visit  to find out more about the survey.

Ocular Allergy Interviews

A research team at Deakin University are currently conducting a research project that is part of a PhD which aims to interview health practitioners on their attitudes, perspectives, experiences, and influences regarding Ocular Allergy (OA). This study has received Deakin University Ethics Approval (reference number: SEBE-2022-73).

You are eligible to take part in this study if you are an Allergist, who is AHPRA registered, practicing in Australia and fluent in English. However, if you are in this health field but are not fully qualified (i.e. students, interns, residents, registrars, and/or in training), then you are ineligible.

If you agree to be involved, the researchers will organise a day and time with you personally to be interviewed via Zoom. This will be a maximum of 60 minutes. This will be audio recorded – video is not required.

Participation is confidential and voluntary. You are under no obligation to take part.

If you are interested and would like to receive a copy of the Plain Language Statement, or further information, please contact [This email address is being protected from spambots. You need JavaScript enabled to view it.]or [This email address is being protected from spambots. You need JavaScript enabled to view it.].

Research Study Participation: 'Feeding characteristics and behaviours in young children with food allergies - Perspectives of Australian health professionals'

We are inviting you to take part in a research study investigating the perspectives and current practice patterns of Australian health professionals who work with children with feeding difficulties who also have food allergies, or a history of food allergies.

Involvement includes completing an anonymous online survey, which will take approximately 20 minutes of your time. Further details including the participant information form are available upon clicking the link below.

Link here:

Seasonal Hay fever (Allergic Rhinitis) Study

There is a clinical study for an investigational nasal spray which is being investigated for the reduction of symptoms of hay fever (allergic rhinitis). The nasal spray is drug-free, and all ingredients of the formulation are well-established and generally recognized as safe.

If the study is of interest to you, please register your details at:

VIC (Camberwell)  -

NSW (Darlinghurst) -

QLD (Fortitude Valley) -

Peanut Oral Immunotherapy (OIT) Trial for People Over 16 Years

St Vincent’s Hospital Sydney is recruiting to an Australia-first research trial to help people over 16 years of age, who are living with peanut allergy. We are investigating the effectiveness of combining omalizumab with peanut oral immunotherapy in improving safety and tolerability of peanut immunotherapy in adults. This will not cure peanut allergy, but aims to improve safety and quality of life for those living with peanut allergy into adulthood.

We are seeking participants who are:
-           over the age of 16 and have peanut allergy
-           have not been admitted to ICU for a peanut reaction in the last 5 years
-           not lactating, pregnant or planning pregnancy 
-           and able to commit to 18 study visits over 12 months (7 of the visits take between 4 to 6 hours) 

Prospective participants and their referrers can contact us by email at This email address is being protected from spambots. You need JavaScript enabled to view it.. Include your phone number and the best time for a member of the study team to contact you. Information can also be found at

Content updated June 2023

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia